Global and United States Neuromyelitis Optica Drug Market Research by Company, Type & Application 2013-2025
SUMMARY
Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
Market Segment as follows:
By Type
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
Market Segment as follows:
By Type
- Production Market Share
- Price Rage
- Cost
- Acute attack
- Remission prophylactic treatment
- Pfizer
- FRESENIUS
- TEVA
- SANDOZ
- Intas
- Gyjtrs
- NANG KUANG
- Tianjin Kingyork
- Baxter
- CSL
- Grifols
- Octapharma
- CBOP
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Production Market Share
1.1.2.2 Price Rage
1.1.2.3 Cost
1.1.3 Market by Application
1.1.3.1 Acute attack
1.1.3.2 Remission prophylactic treatment
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Pfizer
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 FRESENIUS
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 TEVA
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 SANDOZ
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Intas
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Gyjtrs
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 NANG KUANG
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Tianjin Kingyork
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Baxter
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 CSL
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Grifols
6.12 Octapharma
6.13 CBOP
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Production Market Share
1.1.2.2 Price Rage
1.1.2.3 Cost
1.1.3 Market by Application
1.1.3.1 Acute attack
1.1.3.2 Remission prophylactic treatment
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Pfizer
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 FRESENIUS
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 TEVA
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 SANDOZ
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Intas
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Gyjtrs
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 NANG KUANG
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Tianjin Kingyork
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Baxter
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 CSL
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Grifols
6.12 Octapharma
6.13 CBOP
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
LIST OF TABLES
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of FRESENIUS
Table Sales Revenue, Volume, Price, Cost and Margin of TEVA
Table Sales Revenue, Volume, Price, Cost and Margin of SANDOZ
Table Sales Revenue, Volume, Price, Cost and Margin of Intas
Table Sales Revenue, Volume, Price, Cost and Margin of Gyjtrs
Table Sales Revenue, Volume, Price, Cost and Margin of NANG KUANG
Table Sales Revenue, Volume, Price, Cost and Margin of Tianjin Kingyork
Table Sales Revenue, Volume, Price, Cost and Margin of Baxter
Table Sales Revenue, Volume, Price, Cost and Margin of CSL
Table Sales Revenue, Volume, Price, Cost and Margin of Grifols
Table Sales Revenue, Volume, Price, Cost and Margin of Octapharma
Table Sales Revenue, Volume, Price, Cost and Margin of CBOP
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of FRESENIUS
Table Sales Revenue, Volume, Price, Cost and Margin of TEVA
Table Sales Revenue, Volume, Price, Cost and Margin of SANDOZ
Table Sales Revenue, Volume, Price, Cost and Margin of Intas
Table Sales Revenue, Volume, Price, Cost and Margin of Gyjtrs
Table Sales Revenue, Volume, Price, Cost and Margin of NANG KUANG
Table Sales Revenue, Volume, Price, Cost and Margin of Tianjin Kingyork
Table Sales Revenue, Volume, Price, Cost and Margin of Baxter
Table Sales Revenue, Volume, Price, Cost and Margin of CSL
Table Sales Revenue, Volume, Price, Cost and Margin of Grifols
Table Sales Revenue, Volume, Price, Cost and Margin of Octapharma
Table Sales Revenue, Volume, Price, Cost and Margin of CBOP
LIST OF FIGURES
Figure Production Market Share Market Size and CAGR 2013-2017 (Million USD)
Figure Production Market Share Market Size and CAGR 2013-2017 (Volume)
Figure Production Market Share Market Forecast and CAGR 2018-2025 (Million USD)
Figure Production Market Share Market Forecast and CAGR 2018-2025 (Volume)
Figure Price Rage Market Size and CAGR 2013-2017 (Million USD)
Figure Price Rage Market Size and CAGR 2013-2017 (Volume)
Figure Price Rage Market Forecast and CAGR 2018-2025 (Million USD)
Figure Price Rage Market Forecast and CAGR 2018-2025 (Volume)
Figure Cost Market Size and CAGR 2013-2017 (Million USD)
Figure Cost Market Size and CAGR 2013-2017 (Volume)
Figure Cost Market Forecast and CAGR 2018-2025 (Million USD)
Figure Cost Market Forecast and CAGR 2018-2025 (Volume)
Figure Acute attack Market Size and CAGR 2013-2017 (Million USD)
Figure Acute attack Market Size and CAGR 2013-2017 (Volume)
Figure Acute attack Market Forecast and CAGR 2018-2025 (Million USD)
Figure Acute attack Market Forecast and CAGR 2018-2025 (Volume)
Figure Remission prophylactic treatment Market Size and CAGR 2013-2017 (Million USD)
Figure Remission prophylactic treatment Market Size and CAGR 2013-2017 (Volume)
Figure Remission prophylactic treatment Market Forecast and CAGR 2018-2025 (Million USD)
Figure Remission prophylactic treatment Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Neuromyelitis Optica Drug Market Size and CAGR 2013-2017 (Million USD)
Figure Global Neuromyelitis Optica Drug Market Size and CAGR 2013-2017 (Volume)
Figure Global Neuromyelitis Optica Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Neuromyelitis Optica Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Neuromyelitis Optica Drug Market Size and CAGR 2013-2017 (Million USD)
Figure United States Neuromyelitis Optica Drug Market Size and CAGR 2013-2017 (Volume)
Figure United States Neuromyelitis Optica Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Neuromyelitis Optica Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Neuromyelitis Optica Drug SWOT List
Figure Healthcare & Medical Porter's Five Forces
Figure Production Market Share Market Size and CAGR 2013-2017 (Million USD)
Figure Production Market Share Market Size and CAGR 2013-2017 (Volume)
Figure Production Market Share Market Forecast and CAGR 2018-2025 (Million USD)
Figure Production Market Share Market Forecast and CAGR 2018-2025 (Volume)
Figure Price Rage Market Size and CAGR 2013-2017 (Million USD)
Figure Price Rage Market Size and CAGR 2013-2017 (Volume)
Figure Price Rage Market Forecast and CAGR 2018-2025 (Million USD)
Figure Price Rage Market Forecast and CAGR 2018-2025 (Volume)
Figure Cost Market Size and CAGR 2013-2017 (Million USD)
Figure Cost Market Size and CAGR 2013-2017 (Volume)
Figure Cost Market Forecast and CAGR 2018-2025 (Million USD)
Figure Cost Market Forecast and CAGR 2018-2025 (Volume)
Figure Acute attack Market Size and CAGR 2013-2017 (Million USD)
Figure Acute attack Market Size and CAGR 2013-2017 (Volume)
Figure Acute attack Market Forecast and CAGR 2018-2025 (Million USD)
Figure Acute attack Market Forecast and CAGR 2018-2025 (Volume)
Figure Remission prophylactic treatment Market Size and CAGR 2013-2017 (Million USD)
Figure Remission prophylactic treatment Market Size and CAGR 2013-2017 (Volume)
Figure Remission prophylactic treatment Market Forecast and CAGR 2018-2025 (Million USD)
Figure Remission prophylactic treatment Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Neuromyelitis Optica Drug Market Size and CAGR 2013-2017 (Million USD)
Figure Global Neuromyelitis Optica Drug Market Size and CAGR 2013-2017 (Volume)
Figure Global Neuromyelitis Optica Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Neuromyelitis Optica Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Neuromyelitis Optica Drug Market Size and CAGR 2013-2017 (Million USD)
Figure United States Neuromyelitis Optica Drug Market Size and CAGR 2013-2017 (Volume)
Figure United States Neuromyelitis Optica Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Neuromyelitis Optica Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Neuromyelitis Optica Drug SWOT List
Figure Healthcare & Medical Porter's Five Forces
